(Q54441485)

29 May 2018

title

Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay. (English)

1 reference

29 May 2018

1 reference

Waldman FM

1

1 reference

29 May 2018

Dolbeare F

series ordinal

2

1 reference

29 May 2018

Gray JW

series ordinal

3

1 reference

29 May 2018

publication date

1 November 1985

1 reference

29 May 2018

number of pages

6

1 reference

inferred from page(s)

published in

Cytometry

1 reference

29 May 2018

volume

6

1 reference

29 May 2018

page(s)

657-662

1 reference

29 May 2018

issue

6

1 reference

29 May 2018

Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

A non-clonogenic assay for the determination of the sensitivity of leukemic cells to chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Evaluation of in vitro predictive assays for acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Predictive relevance for clinical outcome of in vitro sensitivity evaluated through antimetabolic assay

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990060623

7 January 2021

Identifiers

DOI

10.1002/CYTO.990060623

1 reference

29 May 2018

PubMed ID

4064845

1 reference

29 May 2018